Bayer

Bayer’s Oncology Pipeline Gains Traction in Japan, Yet the Glyphosate Clock Keeps Ticking

Brett Shapiro -

Bayer’s Two-Front Story: A Cardiology Data Drop Meets a Legal Clock That Keeps Ticking

kashif hafeez -

Bayer’s Legal Calendar Slips as Supreme Court Ruling Reshapes the Glyphosat Settlement Calculus

Brett Shapiro -

Bayer’s Two-Front Legal Strategy: From Defendant to Plaintiff While Awaiting a Landmark Ruling

kashif hafeez -

Bayer Stock’s Legal Tailwind Meets a Five-Day Slide Ahead of Earnings

Bayer’s $5 Billion Bond Sale Sends Mixed Signals as Legal Wins and Trade Tensions Collide

angelina -

Supreme Court Victory Offers Limited Shelter as Bayer Faces Glyphosate Price Squeeze and Settlement Delays

Brett Shapiro -

Bayer Balances a Two-Decade Bet on Wheat With a Near-Term Overhaul From Apollo and the Courts

angelina -

Bayer Secures €3 Billion Lifeline From Apollo While Pushing to Dismiss Thousands of Roundup Cases

Brett Shapiro -

Bayer’s Supreme Court Win Ignites a Landmark Rally — But the Legal Shadow Is Far From Lifted

kashif hafeez -

Bayer’s Legal and Political Battles Converge as Overbought Signals Emerge

Bayer Rides a Supreme Court Win to a 54% Rally, But a $7.25 Billion Decision Looms

kashif hafeez -

Bayer’s Supreme Court Victory Lifts the Fog, but Three Immediate Catalysts Will Determine the Rally’s Staying Power

angelina -

Bayer’s Supreme Court Victory Cuts Legal Risk, but the Missouri Hearing Will Test the Rally’s Staying Power

kashif hafeez -

Bayer’s Pipeline Advances Face a Gauntlet of Supreme Court Ruling and US Tariff Threats

angelina -
123Page 1 of 3